Copyright
©The Author(s) 2017.
World Journal of Clinical Cases. Nov 16, 2017; 5(11): 397-402
Published online Nov 16, 2017. doi: 10.12998/wjcc.v5.i11.397
Published online Nov 16, 2017. doi: 10.12998/wjcc.v5.i11.397
Antibody | Clone | Dilution | Source | NET G2 component | NET G3 component | NEC component |
Chromogranin A | DAK-A3 | 1:100 | DAKO, CA, Unites States | Positive | Positive | Weakly positive |
Synaptophysin | SY38 | 1:20 | DAKO, CA, Unites States | Positive | Positive | Weakly positive |
NCAM | 1B6 | 1:100 | DAKO, CA, Unites States | Positive | Positive | Weakly positive |
Ki-67 | MIB-1 | 1:50 | DAKO, CA, Unites States | 6.50% | 99.50% | 88.10% |
p53 | DO-7 | 1:100 | Novocastra, United Kingdom | Negative | Negative | Negative |
Muc2 | Ccp58 | 1:200 | Novocastra, United Kingdom | Negative | Negative | Negative |
Muc5AC | CLH2 | 1:100 | Novocastra, United Kingdom | Negative | Negative | Negative |
Muc6 | CLH5 | 1:100 | Novocastra, United Kingdom | Negative | Negative | Negative |
CD10 | 56C6 | 1:50 | Novocastra, United Kingdom | Negative | Negative | Negative |
- Citation: Uesugi N, Sugimoto R, Eizuka M, Fujita Y, Osakabe M, Koeda K, Kosaka T, Yanai S, Ishida K, Sasaki A, Matsumoto T, Sugai T. Case of gastric neuroendocrine carcinoma showing an interesting tumorigenic pathway. World Journal of Clinical Cases 2017; 5(11): 397-402
- URL: https://www.wjgnet.com/2307-8960/full/v5/i11/397.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v5.i11.397